title: Synthesis and adrenergic activity of a new series of N-aryl dicyclopropyl ketone oxime ethers: SAR and stereochemical aspects.
abstract: A novel series of 31 N-aryl dicyclopropyl ketone oxime ethers were synthesized and tested for their activity at alpha- and beta-adrenergic receptors. All of the compounds showed greater affinity for beta-than for alpha1-receptor sites. Some compounds had pure antagonist effects whereas some were partial agonists. Several compounds had an antagonist effect matching that of propranolol in in vitro (binding data and pA2 values on rat heart ventricle homogenates and guinea pig spontaneously beating right and electrically driven left atrial isolated preparations, respectively) and in in vivo tests (measurement of antagonism toward isoprenaline-induced tachycardia in anesthetized rats). Furthermore, all of the compounds showed a beta1-adrenergic selectivity (beta2-affinity > 1500 nM).
authors.affiliation: Department of Medicinal Chemistry, EP 811 CNRS, University of Grenoble, 38240 Meylan, France.
authors.forename: M
authors.initials: M
authors.lastname: Blanc
authors.forename: A
authors.initials: A
authors.lastname: Tamir
authors.forename: S
authors.initials: S
authors.lastname: Aubriot
authors.forename: M C
authors.initials: MC
authors.lastname: Michel
authors.forename: M
authors.initials: M
authors.lastname: Bouzoubaa
authors.forename: G
authors.initials: G
authors.lastname: Leclerc
authors.forename: P
authors.initials: P
authors.lastname: Demenge
mesh_terms: D000322:Adrenergic Agonists / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D003521:Cyclopropanes / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D008024:Ligands; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects; D009904:Optical Rotation; D010091:Oximes / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D018340:Receptors, Adrenergic, alpha-1 / Q000187:drug effects / Q000378:metabolism; D011943:Receptors, Adrenergic, beta / Q000187:drug effects / Q000378:metabolism*; D018342:Receptors, Adrenergic, beta-1 / Q000187:drug effects / Q000378:metabolism; D018343:Receptors, Adrenergic, beta-2 / Q000187:drug effects / Q000378:metabolism; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
chemical_list: D000322:Adrenergic Agonists; D000319:Adrenergic beta-Antagonists; D003521:Cyclopropanes; D008024:Ligands; D010091:Oximes; D018340:Receptors, Adrenergic, alpha-1; D011943:Receptors, Adrenergic, beta; D018342:Receptors, Adrenergic, beta-1; D018343:Receptors, Adrenergic, beta-2